Evidence map›Paper›PMID 25585586›Full record

ArticleJournal of inherited metabolic disease2015

The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans.

Marianna Caterino, Anna Pastore, Maria Grazia Strozziero, Gianna Di Giovamberardino, Esther Imperlini, Emanuela Scolamiero, Laura Ingenito, Sara Boenzi, Ferdinando Ceravolo, Diego Martinelli and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. "Classical organic acidurias": diagnosis and pathogenesis.Clinical and experimental medicine · 2017
    Review
  17. Review
  18. Cysteamine revisited: repair of arginine to cysteine mutations.Journal of inherited metabolic disease · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Marianna CaterinoFondazione SDN-IRCCS, Naples, Italy.
Anna Pastore
Maria Grazia Strozziero
Gianna Di Giovamberardino
Esther Imperlini
Emanuela Scolamiero
Laura Ingenito
Sara Boenzi
Ferdinando Ceravolo
Diego Martinelli
Carlo Dionisi-Vici
Margherita Ruoppolo
Bambino Gesù Children's Hospital · ITCeinge Biotecnologie Avanzate (Italy) · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylmalonic acidemia with homocystinuria, cobalamin deficiency type C (cblC) (MMACHC) is the most common inborn error of cobalamin metabolism. Despite a multidrug treatment, the long-term follow-up of early-onset patients is often unsatisfactory, with progression of neurological and ocular impairment. Here, the in-vivo proteome of control and MMACHC lymphocytes (obtained from patients under standard treatment with OHCbl, betaine, folate and L-carnitine) was quantitatively examined by two dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry. Twenty three proteins were found up-regulated and 38 proteins were down-regulated. Consistent with in vivo studies showing disturbance of glutathione metabolism, a deregulation in proteins involved in cellular detoxification, especially in glutathione metabolism was found. In addition, relevant changes were observed in the expression levels of proteins involved in intracellular trafficking and protein folding, energy metabolism, cytoskeleton organization and assembly. This study demonstrates relevant changes in the proteome profile of circulating lymphocytes isolated from treated cblC patients. Some results confirm previous observations in vivo on fibroblast, thus concluding that some dysregulation is ubiquitous. On the other hand, new findings could be tissue-specific. These observations expand our current understanding of the cblC disease and may ignite new research and therapeutic strategies to treat this disorder.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolElectrophoresis, Gel, Two-DimensionalFemaleHomocystinuriaHumansInfantLymphocytesMaleProteomeProteomicsSignal TransductionVitamin B 12 DeficiencyProteome

Identifiers

PMID25585586
OpenAlexW1995910554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.